
The sp2-iminosugar glycolipid 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin (DSO2-ONJ) as selective anti-inflammatory agent by modulation of hemeoxygenase-1 in Bv.2 microglial cells and retinal explants
Keywords: Diabetic retinopathy; Inflammation; p38α MAPK; sp2-iminosugar; Glycolipid; Heme oxygenase-1;